MedTrace Logo

Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE Trial

NCT06026111 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-14

No results posted yet for this study

Summary

The purpose of this study is to examine the feasibility and effects of 12-week exercise training at different intensities among individuals with advanced lung cancer receiving immune checkpoint inhibitors.

The names of the study interventions involved in this study are:

Conditions

Interventions

BEHAVIORAL

High-Intensity Interval Training (HIIT)

Home-based, virtually supervised, aerobic exercise intervention at a high intensity in an interval fashion.

BEHAVIORAL

Moderate-Intensity Continuous Training (MICT)

Home-based, virtually supervised, aerobic exercise intervention at a moderate intensity in a continuous fashion.

Sponsors & Collaborators

Principal Investigators

  • Christina Dieli-Conwright, PhD, MPH · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06026111 on ClinicalTrials.gov